InsiderTrades.com logo

HALO Insider Trading

Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $20,844,740.02

Halozyme Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Halozyme Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Halozyme Therapeutics Share Price & Price History

Current Price: $63.43
Price Change: ▲ Price Increase of +0.16 (0.25%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for HALO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Halozyme Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2026Cortney CaudillCOOSell8,857$67.64$599,087.487,055View SEC Filing Icon  
3/9/2026Cortney CaudillCOOSell20,000$67.80$1,356,000.0014,366View SEC Filing Icon  
3/4/2026Helen TorleyCEOSell10,000$70.21$702,100.00767,780View SEC Filing Icon  
3/2/2026Helen TorleyCEOSell20,000$69.69$1,393,800.00767,780View SEC Filing Icon  
2/5/2026Helen TorleyCEOSell10,000$78.64$786,400.00708,719View SEC Filing Icon  
2/3/2026Helen TorleyCEOSell20,000$76.12$1,522,400.00708,719View SEC Filing Icon  
1/5/2026Bernadette ConnaughtonDirectorSell2,000$70.25$140,500.0040,123View SEC Filing Icon  
12/1/2025Bernadette ConnaughtonDirectorSell829$71.60$59,356.4042,123View SEC Filing Icon  
12/1/2025Helen TorleyCEOSell16,569$68.92$1,141,935.48708,719View SEC Filing Icon  
11/11/2025Helen TorleyCEOSell20,000$69.13$1,382,600.00733,719View SEC Filing Icon  
11/10/2025Bernadette ConnaughtonDirectorSell2,000$68.48$136,960.0042,952View SEC Filing Icon  
11/1/2025Cortney CaudillCOOSell4,263$65.19$277,904.9712,737View SEC Filing Icon  
10/3/2025Helen TorleyCEOSell20,000$69.03$1,380,600.00733,719View SEC Filing Icon  
10/1/2025Bernadette ConnaughtonDirectorSell2,000$75.24$150,480.0044,952View SEC Filing Icon  
10/1/2025Helen TorleyCEOSell20,000$75.35$1,507,000.00733,719View SEC Filing Icon  
9/22/2025Nicole LabrosseCFOSell2,227$77.95$173,594.6522,079View SEC Filing Icon  
9/10/2025Nicole LabrosseCFOSell20,000$75.71$1,514,200.0024,306View SEC Filing Icon  
9/3/2025Helen TorleyCEOSell20,000$74.44$1,488,800.00733,719View SEC Filing Icon  
9/2/2025Bernadette ConnaughtonDirectorSell4,000$73.68$294,720.0046,952View SEC Filing Icon  
8/12/2025Helen TorleyCEOSell20,000$63.51$1,270,200.00733,719View SEC Filing Icon  
7/9/2025Helen TorleyCEOSell20,000$56.43$1,128,600.00733,719View SEC Filing Icon  
6/24/2025Helen TorleyCEOSell20,000$53.73$1,074,600.00733,719View SEC Filing Icon  
6/20/2025Helen TorleyCEOSell20,000$52.96$1,059,200.00733,719View SEC Filing Icon  
4/28/2025Jeffrey William HendersonDirectorSell4,497$60.37$271,483.8928,611View SEC Filing Icon  
4/1/2025Jeffrey William HendersonDirectorSell503$64.05$32,217.1533,108View SEC Filing Icon  
3/3/2025Jeffrey William HendersonDirectorSell5,000$58.69$293,450.0033,611View SEC Filing Icon  
2/27/2025Michael J. LaBarreSVPSell1,697$58.28$98,901.16173,756View SEC Filing Icon  
2/25/2025Michael J. LaBarreSVPSell10,000$58.05$580,500.00185,453View SEC Filing Icon  
2/3/2025Jeffrey William HendersonDirectorSell5,000$56.30$281,500.0038,611View SEC Filing Icon  
1/6/2025Jeffrey William HendersonDirectorSell10,000$50.01$500,100.0043,611View SEC Filing Icon  
10/16/2024Michael J. LaBarreSVPSell10,000$53.26$532,600.00173,756View SEC Filing Icon  
10/9/2024Helen TorleyCEOSell10,000$52.58$525,800.00676,744View SEC Filing Icon  
9/25/2024Helen TorleyCEOSell10,000$56.34$563,400.00676,744View SEC Filing Icon  
9/18/2024Michael J. LaBarreSVPSell10,000$62.03$620,300.00173,756View SEC Filing Icon  
9/12/2024Helen TorleyCEOSell10,000$59.20$592,000.00676,744View SEC Filing Icon  
9/10/2024Helen TorleyCEOSell10,000$59.09$590,900.00676,744View SEC Filing Icon  
8/21/2024Michael J. LaBarreSVPSell10,000$61.75$617,500.00168,176View SEC Filing Icon  
8/14/2024Matthew L. PosardDirectorSell9,881$57.70$570,133.7069,874View SEC Filing Icon  
8/12/2024Matthew L. PosardDirectorSell10,000$55.72$557,200.0089,755View SEC Filing Icon  
7/24/2024Michael J. LaBarreSVPSell10,000$55.12$551,200.00168,176View SEC Filing Icon  
7/22/2024Nicole LabrosseCFOSell5,000$53.93$269,650.0015,480View SEC Filing Icon  
6/27/2024Nicole LabrosseCFOSell10,000$51.93$519,300.0015,480View SEC Filing Icon  
6/11/2024Matthew L. PosardDirectorSell10,000$50.01$500,100.00109,755View SEC Filing Icon  
5/22/2024Michael J. LaBarreSVPSell10,000$45.38$453,800.00168,176View SEC Filing Icon  
4/17/2024Michael J. LaBarreSVPSell10,000$38.49$384,900.00168,176View SEC Filing Icon  
3/12/2024Michael J. LaBarreSVPSell10,000$41.64$416,400.00156,558View SEC Filing Icon  
2/28/2024Michael J. LaBarreSVPSell10,000$39.55$395,500.00156,558View SEC Filing Icon  
12/12/2023Michael J. LaBarreSVPSell10,000$39.63$396,300.00151,911View SEC Filing Icon  
10/17/2023Michael J. LaBarreSVPSell10,000$36.52$365,200.00151,911View SEC Filing Icon  
9/19/2023Michael J. LaBarreSVPSell10,000$39.10$391,000.00151,911View SEC Filing Icon  
8/31/2023Helen TorleyCEOSell10,000$42.82$428,200.00623,666View SEC Filing Icon  
8/29/2023Helen TorleyCEOSell10,000$42.40$424,000.00623,666View SEC Filing Icon  
8/22/2023Michael J. LaBarreSVPSell10,000$42.41$424,100.00151,911View SEC Filing Icon  
8/22/2023Michael J. LaBarreSVPSell10,000$42.41$424,100.00151,911View SEC Filing Icon  
8/17/2023Helen TorleyCEOSell10,000$43.18$431,800.00623,666View SEC Filing Icon  
8/14/2023James M. DalyDirectorSell10,000$43.74$437,400.0020,503View SEC Filing Icon  
8/11/2023James M. DalyDirectorSell10,000$43.71$437,100.0030,503View SEC Filing Icon  
7/26/2023Helen TorleyCEOSell10,000$42.69$426,900.00623,666View SEC Filing Icon  
7/18/2023Michael J. LaBarreSVPSell10,000$40.43$404,300.00141,911View SEC Filing Icon  
6/21/2023Michael J. LaBarreSVPSell10,000$36.00$360,000.00141,911View SEC Filing Icon  
4/18/2023Michael J. LaBarreSVPSell10,000$36.00$360,000.00141,911View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

97.79% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HALO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Halozyme Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC82,323$5.58M0.0%+1,202.4%0.070%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.5,586$0.38M0.0%+20.4%0.005%Search for SEC Filing on Google Icon
3/13/2026World Investment Advisors10,014$0.67M0.0%N/A0.008%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC196,600$13.23M0.0%+1,554.7%0.167%Search for SEC Filing on Google Icon
3/9/2026EMC Capital Management3,532$0.24M0.1%-15.0%0.003%Search for SEC Filing on Google Icon
3/6/2026Hsbc Holdings PLC82,323$5.58M0.0%+1,202.4%0.070%Search for SEC Filing on Google Icon
2/25/2026MidFirst Bank3,123$0.21M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/24/2026Pacer Advisors Inc.937,293$63.08M0.1%+95.7%0.794%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC196,329$13.21M0.0%+1,552.5%0.167%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV11,096$0.75M0.0%-5.7%0.009%Search for SEC Filing on Google Icon
2/18/2026Caitlin John LLC6,911$0.47M0.3%N/A0.006%Search for SEC Filing on Google Icon
2/18/2026First Citizens Bank & Trust Co.8,913$0.60M0.0%+2.8%0.008%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury57,516$4.12M0.0%+38.9%0.049%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC8,803$0.59M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp57,623$3.89M0.0%+63.1%0.049%Search for SEC Filing on Google Icon
2/18/2026Coastal Bridge Advisors LLC14,656$0.99M0.1%N/A0.012%Search for SEC Filing on Google Icon
2/18/2026Fuller & Thaler Asset Management Inc.1,379,575$92.85M0.3%+0.6%1.173%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC11,576$0.78M0.0%+67.0%0.010%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC510,949$34.39M0.3%+8.5%0.434%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management26,431$1.78M0.0%+1.2%0.022%Search for SEC Filing on Google Icon
2/18/2026Utah Retirement Systems6,154$0.41M0.0%-5.0%0.005%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC754,514$50.78M0.2%-28.7%0.642%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC10,984$0.74M0.2%+34.8%0.009%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC188,100$12.66M0.2%-1.3%0.160%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Fundamental Investments LLC3,468$0.23M0.0%-23.2%0.003%Search for SEC Filing on Google Icon
2/18/2026Infrastructure Capital Advisors LLC7,300$0.49M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC863,956$58.14M0.0%-9.8%0.735%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC439,708$29.59M0.1%+73.8%0.374%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP90,759$6.11M0.1%-27.0%0.077%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP15,536$1.05M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC52,315$3.52M0.0%+14.8%0.044%Search for SEC Filing on Google Icon
2/17/2026Caisse de depot et placement du Quebec1,224,009$82.38M0.1%+57.6%1.041%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC3,619$0.24M0.0%-94.1%0.003%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC1,158,359$77.96M0.0%+19.6%0.985%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC3,216$0.22M0.1%+4.2%0.003%Search for SEC Filing on Google Icon
2/17/2026EFG International AG51,518$3.47M0.1%N/A0.044%Search for SEC Filing on Google Icon
2/17/2026ArrowMark Colorado Holdings LLC626,218$42.14M0.9%-32.3%0.532%Search for SEC Filing on Google Icon
2/17/2026Laird Norton Wetherby Trust Company LLC8,499$0.57M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/17/2026Amundi20,148$1.36M0.0%+124.4%0.017%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC6,328$0.43M0.0%-84.9%0.005%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD242,038$16.29M0.0%-70.7%0.206%Search for SEC Filing on Google Icon
2/17/2026Vinva Investment Management Ltd16,811$1.13M0.0%+59.7%0.014%Search for SEC Filing on Google Icon
2/17/2026Steamboat Capital Partners LLC144,240$9.71M2.7%+1.2%0.123%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.199,266$13.41M0.0%-19.8%0.169%Search for SEC Filing on Google Icon
2/17/2026Advisory Services Network LLC12,719$0.86M0.0%-2.9%0.011%Search for SEC Filing on Google Icon
2/17/2026Harvey Capital Management Inc.56,340$3.79M0.8%-2.6%0.048%Search for SEC Filing on Google Icon
2/17/2026Mubadala Investment Co PJSC35,815$2.41M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/17/2026Public Employees Retirement System of Ohio38,217$2.57M0.0%-1.7%0.032%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System110,960$7.47M0.0%-4.9%0.094%Search for SEC Filing on Google Icon
2/17/2026Clark Capital Management Group Inc.143,886$9.68M0.1%-29.1%0.122%Search for SEC Filing on Google Icon
2/17/2026Kemnay Advisory Services Inc.1,697$0.11M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors56,586$3.81M0.0%+17.4%0.048%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC6,976$0.47M0.0%-11.8%0.006%Search for SEC Filing on Google Icon
2/17/2026Aster Capital Management DIFC Ltd2,566$0.17M0.1%+40.7%0.002%Search for SEC Filing on Google Icon
2/17/2026Cynosure Group LLC7,063$0.48M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Faithward Advisors LLC23,070$1.55M0.2%N/A0.020%Search for SEC Filing on Google Icon
2/16/2026OMERS ADMINISTRATION Corp50,089$3.37M0.0%+238.4%0.043%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC413,521$27.83M0.0%+15.5%0.352%Search for SEC Filing on Google Icon
2/16/2026TritonPoint Partners LLC4,373$0.29M0.2%N/A0.004%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC30,669$2.06M0.0%-2.2%0.026%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC27,995$1.88M0.0%-58.9%0.024%Search for SEC Filing on Google Icon
2/16/2026Horizon Investment Services LLC30,712$2.07M0.7%+1.4%0.026%Search for SEC Filing on Google Icon
2/16/2026Kennedy Capital Management LLC433,766$29.19M0.6%+13.1%0.369%Search for SEC Filing on Google Icon
2/16/2026Landscape Capital Management L.L.C.25,131$1.69M0.1%+36.4%0.021%Search for SEC Filing on Google Icon
2/16/2026Epoch Investment Partners Inc.533,359$35.90M0.2%-10.6%0.454%Search for SEC Filing on Google Icon
2/16/2026Aurora Investment Counsel25,035$1.69M0.9%-7.1%0.021%Search for SEC Filing on Google Icon
2/16/2026Brown Advisory Inc.35,870$2.41M0.0%+2.6%0.031%Search for SEC Filing on Google Icon
2/16/2026Arrowstreet Capital Limited Partnership3,222,507$216.88M0.1%-2.1%2.740%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC11,706$0.79M0.0%+71.6%0.010%Search for SEC Filing on Google Icon
2/13/2026CreativeOne Wealth LLC12,701$0.86M0.0%-7.9%0.011%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP497,200$33.46M0.0%+26.3%0.423%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 159,650$10.77M0.0%-8.7%0.136%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co85,292$5.74M0.0%-8.6%0.073%Search for SEC Filing on Google Icon
2/13/2026Segall Bryant & Hamill LLC307,224$20.68M0.3%+41.9%0.261%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP561,577$37.79M0.1%+15.3%0.478%Search for SEC Filing on Google Icon
2/13/2026UMB Bank n.a.1,296$87K0.0%+18.2%0.001%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp18,848$1.27M0.0%+8.3%0.016%Search for SEC Filing on Google Icon
2/13/2026PCM Encore LLC3,312$0.22M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP125,000$8.41M0.0%+3,656.0%0.106%Search for SEC Filing on Google Icon
2/13/2026Commerce Bank17,942$1.21M0.0%+107.6%0.015%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC1,399$95K0.0%+21.9%0.001%Search for SEC Filing on Google Icon
2/13/2026Bank of Nova Scotia5,531$0.37M0.0%-93.1%0.005%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group137,139$9.28M0.0%+1.2%0.117%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.876,957$59.02M0.2%-2.4%0.746%Search for SEC Filing on Google Icon
2/13/2026Vivaldi Capital Management LP27,689$1.86M0.3%-16.5%0.024%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC94,832$6.38M0.0%-12.4%0.081%Search for SEC Filing on Google Icon
2/13/2026Arkadios Wealth Advisors20,474$1.38M0.0%+24.9%0.017%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP1,011,782$68.09M0.0%+30.3%0.860%Search for SEC Filing on Google Icon
2/13/2026Integrated Wealth Concepts LLC3,563$0.24M0.0%+6.8%0.003%Search for SEC Filing on Google Icon
2/13/2026OpenArc Corporate Advisory LLC19,303$1.30M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.1,241,829$83.58M0.0%-1.5%1.056%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey49,242$3.31M0.0%-9.3%0.042%Search for SEC Filing on Google Icon
2/13/2026Van ECK Associates Corp8,713$0.59M0.0%+5.0%0.007%Search for SEC Filing on Google Icon
2/13/2026Royal London Asset Management Ltd.1,371,271$92.29M0.2%+19.9%1.166%Search for SEC Filing on Google Icon
2/13/2026Victory Capital Management Inc.599,158$40.32M0.0%-3.8%0.509%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC29,549$1.99M0.0%-40.3%0.025%Search for SEC Filing on Google Icon
2/13/2026Vontobel Holding Ltd.3,790$0.26M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/13/2026Boston Partners487,069$33.11M0.0%+9.5%0.414%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC733,562$49.37M0.0%+124.4%0.624%Search for SEC Filing on Google Icon
2/13/2026Quadrant Capital Group LLC8,196$0.55M0.0%-3.6%0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Halozyme Therapeutics logo
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Read More on Halozyme Therapeutics

Today's Range

Now: $63.43
Low: $62.51
High: $63.78

50 Day Range

MA: $71.53
Low: $63.27
High: $81.23

52 Week Range

Now: $63.43
Low: $47.50
High: $82.22

Volume

3,570,365 shs

Average Volume

1,579,046 shs

Market Capitalization

$7.49 billion

P/E Ratio

25.47

Dividend Yield

N/A

Beta

0.98

Who are the company insiders with the largest holdings of Halozyme Therapeutics?

Halozyme Therapeutics' top insider shareholders include:
  1. Helen Torley (CEO)
  2. Michael J Labarre (SVP)
  3. Matthew L Posard (Director)
  4. Bernadette Connaughton (Director)
  5. Jeffrey William Henderson (Director)
  6. Nicole Labrosse (CFO)
  7. Cortney Caudill (COO)
Learn More about top insider investors at Halozyme Therapeutics.

Who are the major institutional investors of Halozyme Therapeutics?

Halozyme Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 9.84%
  2. Arrowstreet Capital Limited Partnership — 2.74%
  3. Geode Capital Management LLC — 2.07%
  4. Snyder Capital Management L P — 2.04%
  5. Dimensional Fund Advisors LP — 1.79%
  6. Norges Bank — 1.62%
Learn More about top institutional investors of Halozyme Therapeutics stock.

Which major investors are selling Halozyme Therapeutics stock?

Within the last quarter, HALO stock was sold by these institutional investors:
  1. BNP Paribas Financial Markets
  2. Price T Rowe Associates Inc. MD
  3. Renaissance Technologies LLC
  4. Snyder Capital Management L P
  5. Voloridge Investment Management LLC
  6. ArrowMark Colorado Holdings LLC
  7. Congress Asset Management Co.
  8. TD Asset Management Inc
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
  1. Helen Torley (CEO)
  2. Michael J Labarre (SVP)
  3. Matthew L Posard (Director)
  4. Bernadette Connaughton (Director)
  5. Jeffrey William Henderson (Director)
Learn More investors selling Halozyme Therapeutics stock.

Which major investors are buying Halozyme Therapeutics stock?

Within the last quarter, HALO stock was acquired by institutional investors including:
  1. Norges Bank
  2. William Blair Investment Management LLC
  3. Mizuho Markets Americas LLC
  4. Jupiter Asset Management Ltd.
  5. Pacer Advisors Inc.
  6. Caisse de depot et placement du Quebec
  7. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  8. Arbejdsmarkedets Tillaegspension